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Cr(III) complexes with [NNN]-heteroscorpionate pyrazolyl ligands of the type Pz’2CHX (Pz’ =
pyrazol-l-yl (Pz), or 3,5-dimethylpyrazol-1-yl (PzMe); X = N-containing heterocyclic ring or amine
CH2NR1R2; R1, R2 = H or alkyl) have been prepared. Upon activation with MAO, they are active for
selective ethylene trimerisation to 1-hexene. The effects of the hetero-functional group and chelate ring
size on the catalytic performance have been examined. The pre-catalysts with an N-heterocycle
substituent show highest activity [32400–53000 g/(g Cr h-1)] and total C6 selectivities (>97.6%) as well
as 1-hexene selectivity (>96.0%) among hexenes. The X-ray single-crystal crystallographic analysis of
CrCl3[PzMe2CH2NCH2Ph] and CrCl3[PzMe2CH2NCH2Fc] (Fc = ferrocenyl) shows a tridentate
coordination on the fac-octahedral Cr(III) sphere with the Cr-N bond length dependent on the
N-substituent.
Introduction
There has been an increasing use of hybrid and hemilabile
ligands to enhance catalytic performance.1 Complexes of these
ligands are probably most appropriate in catalytic systems that
demand a high level of skeletal, coordination and electronic
dynamics.2 One of the typical examples is CrIII-catalysed ethylene
oligomerisation which is well promoted by nimble bi- and triden-
tate ligands.3 Herein our primary contribution is in functional
ligands with heterocyclic substituents that are structurally flexible,
electronically adaptable and having distinctive but not dominating
donicity.4 Other advantages include aerial and aqua stability,
and, very importantly, being amenable to easy modification by
established synthetic methodologies. These are best exemplified in
our recent use of CrIII-catalysed selective olefin oligomerisation
supported by heteroscorpionate pyrazolyl ligands of the type
Pz’2CHCH2XR’ (Pz’ = pyrazol-l-yl (Pz), or 3,5-dimethylpyrazol-
1-yl (PzMe); X = O or S, R = alkyl or aryl) with [NNO] or
[NNS] donor sets.5 (A, Fig. 1) Another example is the revelation
of some intriguing intermetallic interactions between AlMe3 and
the Cr(III) sphere through the use of bis(pyrazol-1-yl)-methane-
derived [NNN] ligands ([NNN] = Pz’2CHX (X = N-heterocyclic
ring (B) or CH2NR1R2 (R1, R2 = H or alkyl) (C)).6 (Fig. 1)
The use of pyrazoles as weak-medium ligands with adaptable
nitrogen donor sites offers an alternative to the more established
BP diphosphine3a,e and the Sasol mixed heteroatomic systems3b,c in
olefin trimerisation. Hybrid donors are expected to augment the
facile association-dissociation equilibria which could be key to
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Fig. 1 [NNO], [NNS] and [NNN]-heteroscorpionate pyrazolyl Cr(III)
complexes.
isomeric selectivity.3b,5 In this paper, we shall demonstrate further
the coordinative and structural adaptation of the bis-pyrazoyl
motif through the introduction of a range of nitrogen appendices,
and the significant effect of the latter on ethylene trimerisation.
The use of related tri(pyrazolyl)methane ligand with Cr(III) in
selective trimerisation has been patented.7
Results and discussion
Synthesis of [NNN]-heteroscorpionate pyrazolyl Cr(III) complexes
1–7 with a heterocycle as ligand appendix and complexes 8–14 with
an amine appendix
The tripodal [NNN] ligands HC(Pz’)2Py (Py = pyridyl) (L1)
was prepared by a CoCl2-catalysed condensation of aldehydes
with 1,1¢-carbonyl-dipyrazole Pz’2C=O (from pyrazolate and
phosgene).8 Using a modified route9 and avoiding the use of dan-
gerous phosgene, we have synthesised HC(PzMe)2(PyMe) (PyMe =
methylpyridyl) (L2) and HC(Pz’)2(ImdMeRR) (ImdMe = methylim-
idazole; R = H (L3), Me (L4), C4H4 (L5)) from a condensation
reaction of the corresponding aldehydes with (Pz’)2S=O (from
thionyl chloride). Tris(3,5-dimethyl-pyrazolyl)methane (L6) was
prepared by a literature method from the CHCl3–H2O phase
transfer reaction of 3,5-dimethyl-pyrazole.10 Ligand L7, with a
longer third pyrazolyl pendant, was also prepared for comparison.
Treatment of L1-L7 with [CrCl3(THF)3] in THF afforded the

































































corresponding [CrCl3L] complexes 1–7 in good yields (88–95%).
(Scheme 1)
Scheme 1 Syntheses of L1-L7 and their Cr(III) complexes 1–7.
Among the large number of known bis-pyrazolyl heteroscor-
pionate ligands, very few are functionalised by amine.11 As these
amine-appended ligands have potential uses as supramolecular
probes, radiopharmaceutical ligands, and functional materials
as well as some broad applications in catalysis,11 we have pre-
pared seven [NNN] ligands with different amino substituents,
PzMe2CHCH2NHCH2R, (R = Ph L8, n-pentyl L9, ferrocenyl L12),
and PzMe2CHCH2NR1R2 (R1 = H, R2 = cyclohexyl L10; R1,
R2 = -(CH2)5- L11), Pz2CHCH2NHCH2Ph L14.(Scheme 2) Those
with aliphatic amine appendices are obtained from condensation
of Pz2CHCH2NH2 with the appropriate aldehydes, followed by
reduction with NaBH4.11a Using this method, L8, L9, L12, L14 were
Scheme 2 Syntheses of L8–L14 and their Cr(III) complexes 8–14.
Table 1 Summary of crystallographic data for 8 and 12
8 12
Formula C21H28Cl3CrN6 C27H35Cl3CrFeN7
Formula weight 522.84 671.82
T , K 295(2) 223(2)
crystal system Monoclinic Orthorhombic
space group P2(1)/n P2(1)2(1)2(1)
a, Å 12.0925(16) 11.0249(3)
b, Å 14.7579(19) 15.2942(3)
c, Å 14.0641(19) 18.2787(8)
a, deg 90 90
b, deg 103.897(4) 90
g , deg 90 90
Volume, Å3 2436.4(6) 3082.1(2)
Z 4 4
Dcalc, Mg m-3 1.425 1.448
absorption coefficient, mm-1 0.819 1.113
F(000) 1084 1388
crystal size, mm 0.20 ¥ 0.16 ¥ 0.06 0.18 ¥ 0.14 ¥ 0.06







goodness of fit on F2 1.043 0.994
final R indices [I >2s(I)]a R1 = 0.0624 R1 = 0.0429
wR2 = 0.1507 wR2 = 0.0882
lgst diff peak and hole, e Å-3 0.658 and -0.316 0.413 and -0.265
a R1 = ∑‖F o| - |F c‖/
∑
|F o|; Rw = [
∑
w(|F o2| - |F c2|)2/
∑
w|F o2|2]1/2.
prepared with good yields, and PzMe2CHCH2NH2 (L13) was synthe-
sised accordingly. Since the reported synthesis of Pz’2CHCH2NH2
is tedious,11a we have developed a simpler and more direct method,
starting from the nucleophilic displacement of bromoacetaldehyde
diethyl acetal with an appropriate amine, followed by thermal
condensation of the resultant aminoacetaldehyde diethyl acetal
with two-fold of pyrazole. Using this method, L10 and L11 were
prepared with yields of 61% and 73%, respectively. Treatment
of the L8-L14 with [CrCl3(THF)3] afforded the corresponding
[CrCl3L] 8–14 in good yields (90–93%). (Scheme 2)
In order to establish the coordination mode of these tridentate
ligands, complexes 8 and 12 were selected for structural analysis by
single-crystal X-ray diffraction (Table 1). Complexes 8 and 12 have
distorted fac-octahedral structures with tridentate coordination
of the tripodal pyrazolyl ligand, which results in the convergence
of three nitrogen donors at the Cr(III) center to give a tricyclic-
cage-like structure (Fig. 2 and Fig. 3). In both cases, the Cr-N(sp2)
(pyrazole) bonds [2.080(3), 2.117(4) Å for 8 and 2.107(3),
2.110(3) Å for 12] are shorter and presumably stronger than the
Cr-N(sp3) (amine) bonds [2.137(3) Å for 8 and 2.117(3) Å for 12],
albeit the difference is not significant. These structures suggest
that the Cr-N(amine) length, and presumably donor strength,
of the tether amine can indeed be tuned by its substituent.
Similar lengths are found in the related Cr(III) pyrazolyl
complexes, [2.096(2)-2.102(2) Å for CrCl3[PzMe2CHCH2SMe],5
2.076(3)-2.089(3) Å for CrCl3[PzMe2CHCH2OPh],4 2.116(1)-
2.122(1) Å for CrCl3[(PzMeCH2CH2)2O],12 2.051(3)-2.086(3) Å
for CrCl3[(Ph4P)+(HBPz3)-]13 and amine complexes
[2.106(2) Å for CrCl3[(EtSCH2CH2)2NH],3c 2.139(3) Å for
CrCl3[(Ph2PCH2CH2)2NH],3b 2.120(3) Å for CrCl3[6-Me-2-
PyCH2)2NnPr].14

































































Table 2 Ethylene trimerisation catalysed by 1–7a
oligomer distribution (wt%)
Entry (complex) mmol of Cr PE (wt%) C4 C6 C8 C≥10 1-C6 (wt%) activity(g/(g Cr h-1))
1 (1)b 8.9 <0.1 <0.1 97.8 1.1 1.0 99.3 38200
2 (2) 10.5 15.1 <0.1 49.4 19.1 31.4 96.1 670
3 (3)b 7.9 <0.1 <0.1 98.5 1.4 — 99.1 53000
4 (3)c 9.1 <0.1 <0.1 97.8 1.3 0.8 99.2 35000
5 (4) 8.5 <0.1 <0.1 93.4 1.5 5.0 99.3 11000
6 (5) 8.5 <0.1 <0.1 97.9 1.0 1.0 99.2 43000
7 (6)b 8.7 <0.1 <0.1 97.6 1.3 1.0 98.4 32400
8 (7) 10.1 7.5 13.6 22.5 24.0 39.9 97.8 27000
a Conditions: 200 equiv. MAO, 30 bar of ethylene, 60 mL toluene, 80 ◦C, 30 min. b Our previous work.6 c 60 min.
Fig. 2 Molecular structure of CrCl3[PzMe2CH2NCH2Ph], 8 with
30% probability ellipsoids (H atoms omitted for clarity). Selected
bond distances (Å) and angles (◦): Cr–N(1) 2.082(3), Cr–N(3)
2.117(3), Cr–N(5) 2.134(4), Cr–Cl(1) 2.294(1), Cr–Cl(2) 2.307(1),
Cr–Cl(3) 2.310(1), N(1)–Cr–N(3) 85.33(13), N(1)–Cr–Cl(1) 91.94(10),
N(1)–Cr–Cl(2) 90.65(10), Cl(1)–Cr–Cl(2) 94.73(5), N(3)–Cr–Cl(2)
172.79(10), N(5)–Cr–Cl(3) 84.03(11), N(5)–Cr–Cl(1) 171.39(12).
Fig. 3 Molecular structure of CrCl3[PzMe2CH2NCH2Fc] (Fc = fer-
rocenyl), 12 with 30% probability ellipsoids (H atoms omitted for
clarity). Selected bond distances (Å) and angles (◦): Cr–N(1) 2.110(3),
Cr–N(3) 2.107(3), Cr–N(5) 2.117(3), Cr–Cl(1) 2.313(1), Cr–Cl(3) 2.313(1),
Cr–Cl(2) 2.310(1), N(3)–Cr–N(1) 85.55(10), N(3)–Cr–N(5) 80.10(11),
N(1)–Cr–N(5) 89.33(11), N(1)–Cr–Cl(2) 91.51(8), N(3)–Cr–Cl(2)
173.30(8), Cl(2)–Cr–Cl(3) 92.23(4), Cl(2)–Cr–Cl(1) 93.49(3).
Ethylene trimerisation
Complexes 1–7 were compared for their activity and selectivity
toward ethylene trimerisation at 80 ◦C under 30 bar pressure of
ethylene and in the presence of 200 molar excess of MAO (Table 2).
The precatalysts 1, 3, 5, and 6 with a heterocycle appendix, viz.
pyridyl, imidazolyl, benzimidazolyl, or pyrazolyl group, are highly
selective towards trimerisation (total C6 selectivities >97.6%) with
good activities of 32400–53000 g/(g Cr h-1), and a high level of
1-hexene selectivity (>96.0%) (entries 1, 3, 6 and 7). Complex
3, with methylimidazole together with the two pyrazole groups,
in particular shows the highest activity (53000 g/g h-1) and C6
selectivity (98.5%). Comparison of 1 and 2, as well as 3 and 4
suggests that introduction of a methyl group ortho to the nitrogen
in the pyridine (2) or imidazolyl ring (4) respectively remarkably
diminishes the catalyst activity (compare entry 1 with 2; entry 3
with 5). This may be attributed to the increasing steric hindrance
on the N donor. A comparison of 2, 4 and 6 suggests that for a
stronger donor such as pyridyl and imidazolyl, the adverse steric
effect brought along by a neighboring group appears to be more
pronounced. Carney et al. also found that in the Cr(III) complexes
of bis(2-pyridylmethyl)alkylamine ligands, unsubstituted ligands
yield fac complexes whereas 6-methylsubstituted ligands result in
mer isomers, and the former is 30–40 times more active in ethylene
polymerization than the latter counterpart.14 The difference is
probably a combined effect of steric and electronic factors, the
latter of which could be measured by the stronger (pyridyl) donor
at the fac vs the mer conformation (Cr-N(fac)av bond: 2.085 Å;
Cr-N(mer)av bond: 2.149 Å).14
Extension of the pyrazolyl pendant by introducing a methylene
to 6 giving 7 results in overall lower activity and a significant drop
in C6 selectivity. This can be explained by the formation of a more
fragile 7-membered ring in the latter. With a longer reaction time
of 1 h, the activity of 3 decreases (compare entries 3 and 4), which
suggests a shorter catalyst lifetime.
Related Cr(III) complexes with tridenate [NNN] ligands from
bis(N-methylimidazol-2-yl)-methane give linear 1-alkenes (C4-C30)
with moderate selectivities of 65–79% when activated by MMAO,
under catalytic condition similar to our experiments (40 bar of
ethylene, 100 ◦C).15 The unsatisfactory selectivity can be partially
attributed to the presence of two or three strongly donating
imidazole groups.
The effect of an amine substituent was also evaluated using
8–14 (Table 3). At 80 ◦C under 30 bar of ethylene pressure and
in the presence of 200 molar excess of MAO, these complexes
generally return with much lower activity and selectivity compared
with the analogous 1, 3, 5 and 6 that bear a heterocyclic tether,
possibly due to the stronger donation from sp2 in the latter and
N-H deprotonation during the activation process. The Sasol [SNS]
system, however, is different in which the pyridine-containing

































































Table 3 Ethylene trimerisation catalysed by 8–14a
oligomer distribution (wt%)
Entry (complex) mmol of Cr PE (wt%) C4 C6 C8 C≥10 1-C6 (wt%) activity (g/(g Cr h-1))
1 (8)b 8.0 0.5 — 92.6 3.5 3.9 98.7 10500
2 (8)c 8.2 <0.1 1.4 97.1 0.9 0.6 98.3 8900
3 (9) 8.7 5.3 1.6 79.6 8.8 10.0 97.1 17000
4 (10) 8.5 1.0 2.9 79.1 6.3 11.7 97.3 5100
5 (11) 11.0 19.5 10.2 33.1 4.8 51.9 96.1 14100
6 (12) 7.9 0.7 2.5 87.3 6.5 3.7 97.5 11000
7 (13) 8.5 <0.1 <0.1 93.1 3.8 3.0 99.0 12000
8 (14) 8.1 7.8 3.6 66.5 11.7 18.2 97.1 9800
a Conditions: 200 equiv. MAO, 30 bar of ethylene, 60 mL toluene, 80 ◦C, 30 min. b Our previous work.6 c 60 ◦C.
complexes show much lower activity than their amine analogues.3
The difference may be attributed to their different coordinative
mode, viz. fac vs. mer conformation. The highest selectivities are
found in 8 with a benzyl group and in 13 with a primary amine,
showing total C6 selectivities of 92.6 (8), 93.1% (13) and 1-hexene
selectivities of >91% with activities of 10500 (8) and 12000 g/(g
Cr h-1) (13) (compare entries 1 and 7). At a low temperature
(60 ◦C), 8 achieves a high selectivity up to 97.1% but with a lower
activity (8900 g/(g Cr h-1)) (compare entries 1 with 2). Complex
9 having a long hexyl chain shows higher activity than 8 at the
expense of selectivity (total C6 selectivities of 79.6%) (compare
entries 1 with 3). The enhanced activity could be attributed to a
better solubility of 9 in toluene, probably due to its longer alkyl
chain. In 10, increasing the steric hindrance of N donor atom by
introducing a cyclohexyl amino group results in a lower selectivity
and activity than 8 (compare entries 1 with 4). Replacement
of the secondary amino group by a tertiary amino group (11)
significantly decreases the selectivity and favors the formation of
polyethylene (PE) (compare entries 5 with 1–4), probably due to
the increasing steric hindrance on the N atom in 11. Comparing
10 and 11 with 8 and 13, lower the steric hindrance around the
metal centre seems to help achieve high selectivity in ethylene
trimerisation. Although a redox-active group such as ferrocenyl
tends to have a beneficial role in many catalytic processes,16
including ethylene polymerisation, it seems to have little effect
on the trimerisation, as evident from the activity comparison of
12 with 8 (compare entries 6 with 1). In 14, replacement of the
methyl on the pyrazole rings by hydrogen decreases significantly
the selectivity and favours the formation of PE (compare entries
8 and 1). Tentative comparison of these [NNN] Cr(III) catalysts
with their [NNO] and [NNS] analogues5 suggested that the activity
generally decreases in the order [NNN(heterocyclic ring)] >
[NNO] > [NNN(amine)] > [NNS]. This appears to link the
lower donor ability of the third arm to weaker activity. Further
experiments are needed to understand such relationship.
Conclusion
The use of two pyrazolyl groups in place of the common and
generally softer phosphines and thioethers has brought along some
significant advantages. The fused and hybrid metalla-heterocyclic
ring structures lend stability to an inherently hemilabile system.
These features could offer an explanation to the notable activity
and high selectivity observed. The system enables a large variety
of nitrogen-donors to be attached as the third arm, through which
the lability can be controlled and the electronic character tuned.
It also offers a simple access to all-nitrogen but mixed-hybridised
(sp2-sp3) ligands for catalysis.
Experimental
All reactions were carried out using standard Schlenk techniques
under an inert atmosphere of nitrogen or argon with an M. Braun
Labmaster 130 Inert Gas System. THF, Et2O and toluene were dis-
tilled from sodium–benzophenone. The complex [CrCl3(THF)3]
was prepared as reported.1 Commercial reagents, namely, NaH
(60% dispersion in mineral oil), bromoacetaldehyde diethyl acetal,
MAO (methylaluminoxane) (10 wt.% in toluene) were purchased
from Aldrich and used as received. N-cyclohexyl-acetaldehyde
diethyl acetal (I10)17 and L14 11a were prepared by literature methods.
1H NMR spectra were recorded on Bruker ACF300 300 MHz FT
NMR spectrometers. Mass spectra were obtained on a Finnigan
Mat 95XL-T spectrometer. Elemental analyses were performed
by the microanalytical laboratory in house. Quantitative Gas
Chromatographic analysis of the oligomerisation products was
performed on an Agilent 6890 Series GC instrument with a J&W
DB-1 column working at 36 ◦C for 10 min and then heating
at 10 ◦C min-1 until 250 ◦C. n-Nonane was used as an internal
standard.
Synthesis of (6-methyl-pyridin-2-yl)-bis(3,5-dimethylpyrazol-
1-yl)methane L2, L4, and L5
To a cooled suspension of NaH (1.20 g, 30.0 mmol) in THF
(30 mL) was added 3,5-dimethyl-pyrazole (2.86 g, 30.0 mmol)
and the resulting mixture stirred at 0 ◦C for 2 h. After thionyl
chloride (1.09 mL, 14.9 mmol) was added dropwise, the mixture
was further stirred for 1 h at r.t. 6-Methyl-pyridine-2-aldehyde
(1.80 g, 14.9 mmol) and CoCl2 (100 mg) were added and the
mixture was heated under reflux over 10 h. After cooling to r.t., it
was quenched with water and extracted three times with Et2O (3¥
20 mL). The combined organic phases were dried over anhydrous
NaSO4 and concentrated in vacuo. The resulting residue was
purified by chromatography (ethyl acetate/hexane), and yielded
L2 (2.30 g, 52%) as white powder. 1H NMR (300 MHz, CDCl3):
d 7.54 (t, J = 7.9 Hz, 1H, Py-H), 7.47 (s, 1H, Pz2-CHC), d 7.08
(d, J = 7.7 Hz, 1H, Py-H), 6.76 (d, J = 7.6 Hz, 1H, Py-H), 5.85
(s, 2H, Pz-H), 2.52 (s, 3H, Py-CH3), 2.19 (s, 6H, Pz-CH3), 2.13

































































(s, 6H, Pz-CH3). 13C{1H} NMR (75.47 MHz, CDCl3): d 158.21,
154.85 (s, C(Py)), 148.40, 140.71 (s, C-N(Pz)), 137.00, 122.92,
119.50 (s, C(Py)), 106.97 (s, CH(Pz)), 74.91 (s, N-CH-Py), 24.41
(s, CH3(Py)), 13.76, 11.33 (s, CH3(pz)).
(1,4,5-Trimethylimidazol-2-yl)-bis(3,5-dimethylpyrazol-1-
yl)methane (L4)
This compound was prepared analogously to L2, starting from
NaH (1.20 g, 30.0 mmol), 3, 5-dimethyl-pyrazole (2.86 g,
30.0 mmol), thionyl chloride (1.09 mL, 14.9 mmol), 1,4,5-
trimethylimidazole-2-aldehyde (2.06 g, 14.9 mmol), and CoCl2
(100 mg). Yield: 2.5 g (51%). 1H NMR (300 MHz, CDCl3): d
7.48 (s, 1H, Pz2-CH), 5.85 (s, 2H, Pz-H), 3.18 (s, 3H, N-CH3),
2.17 (s, 6H, Pz-CH3), 2.11 (s, 6H, Pz-CH3), 2.11, 2.10 (s, 6H,
Imidazole-CH3). 13C{1H} NMR (75.47 MHz, CDCl3): d 148.09,
140.78 (s, C-N(Pz)), 138.75, 132.29, 125.02 (s, C(Imin)), 107.15 (s,




This compound was prepared similarly to L2, starting from NaH
(1.20 g, 30.0 mmol), 3, 5-dimethyl-pyrazole (2.86 g, 30.0 mmol),
thionyl chloride (1.09 mL, 14.9 mmol), N-methylbenzimidazole-
2-aldehyde (2.39 g, 14.9 mmol), and CoCl2 (100 mg). Yield:
2.7 g (52%). 1H NMR (300 MHz, CDCl3): d 7.81-7.24 (m,
4H, Benzimidazole-H), 7.76 (s, 1H, Pz2-CHC), 5.92 (s, 2H,
Pz-H), 3.47 (s, 3H, N-CH3), 2.18, 2.17 (s, 12H, Pz-CH3).
13C{1H} NMR (75.47 MHz, CDCl3): d 148.51, 141.18 (s, C-
N(Pz)), 147.64, 141.96, 136.58, 123.18, 122.01, 120.87, 109.26 (s,
C(Benzimidazole)), 107.63 (s, CH(Pz)), 70.50 (s, N-CH), 30.04 (s,
CH3), 13.64, 11.27 (s, CH3(Pz)).
Synthesis of N-[2,2-bis(3,5-dimethylpyrazol-1-yl)ethyl]-piperidine
L7, L10, L11, from N-(3,5-dimethyl-pyrazolyl) acetaldehyde diethyl
acetal (I7)
3,5-Dimethyl-pyrazole (3.38 g, 35.2 mmol) in DMF (10 mL)
was added dropwise to a suspension of NaH (1.4 g of 60%
dispersion in mineral oil, 35.2 mmol) in anhydrous DMF (20 mL)
at ~0 ◦C. The resulting mixture was stirred at r.t. for 2 h. It
was then cooled to ~0 ◦C and bromoacetaldehyde diethyl acetal
(6.94 g, 35.2 mmol) was added. The resultant mixture was stirred
at 80 ◦C for 8 h and then distilled under reduced pressure
to give a residue which was diluted with water and extracted
three times with Et2O. The combined organic phases were dried
over MgSO4 and concentrated in vacuo. The residue was purified
by chromatography (ethyl acetate/hexane), and yielded I7 (5.9 g,
79%) as colorless oil. 1H NMR (300 MHz, CDCl3): d 5.76 (s, 1H,
Pz-H), 4.78 (t, J = 5.4 Hz, 1H, CHCH2), 4.05-4.03(d, J = 5.4 Hz,
2H, CHCH2N), 3.74-3.33 (m, 4H, CH3CH2O), 2.28, 2.23 (s, 6H,
CH3-Pz), 1.13(t, J = 6.9 Hz, 6H, CH3CH2O).
A mixture of 3,5-dimethyl-pyrazole (0.77 g, 8.00 mmol) and I7
(0.85 g, 4.00 mmol) was heated with p-toluenesulfonic acid (0.05
g) and stirred at 190–210 ◦C for 5 h. After ethanol was completely
distilled off, the melt was re-dissolved in 20 mL of Et2O. The
Et2O solution were dried over anhydrous NaSO4 and concentrated
in vacuo. The resulting residue was purified by chromatography
(ethyl acetate/hexane) yielding L7 (0.73 g, 58%) as white powder.
1H NMR (300 MHz, CDCl3): d 6.52 (t, J = 6.6 Hz, 1H, CHCH2),
5.76 (s, 2H, Pz-H), 5.66 (s, 1H, Pz-H), 5.05 (d, J = 6.6 Hz,
2H, CHCH2N), 2.26, 2.24, 2.22 (s, 9H, Pz-CH3), 2.08, 2.06 (s,
6H, Pz-CH3), 1.84 (s, 3H, Pz-CH3), 13C{1H} NMR (75.47 MHz,
CDCl3): d 148.86, 139.63, 106.02 (s, C-N(Pz)), 148.43, 141.17,
104.72 (s, CH(Pz’)), 67.77 (s, N-CH-CH2), 51.14 (s, CH-CH2-N),
13.81, 10.35 (s, CH3(pz)), 13.43, 9.87 (s, CH3(pz’)).
Synthesis of N-cyclohexyl-2,2-bis(3,5-dimethyl-pyrazol)-
1-yl-ethanamine (L10)
This compound was prepared similarly to L7, starting from
3,5-dimethyl-pyrazole (0.77 g, 8.00 mmol) and N-cyclohexyl-
acetaldehyde diethyl acetal (I10) (0.86 g, 4.00 mmol) and was heated
with p-toluenesulfonic acid (0.05 g). Yield: 0.76 g (61%) as colorless
oil. 1H NMR (300 MHz, CDCl3): d 6.30 (t, J = 7.2 Hz, 1H,
CHCH2), 5.77 (s, 2H, Pz-H), 3.63 (d, J = 7.2 Hz, 2H, CHCH2N),
2.50 (m, 1H, NCH), 2.20 (s, 6H, Pz-CH3), 2.11 (s, 6H, Pz-CH3),
1.86-1.00 (m, 10H, Cyclohexyl-H). 13C{1H} NMR (75.47 MHz,
CDCl3): d 148.13, 140.12 (s, C-N(Pz)), 106.97 (s, CH(Pz)), 72.24 (s,
Pz2-CH-CH2), 56.47 (s, CH-CH2-NH), 48.70, 33.85, 26.37, 25.23
(s, C(Cyclohexyl)), 13.89, 11.18 (s, CH3(pz)).
Synthesis of N-[2,2-bis(3,5-dimethylpyrazol-1-yl)ethyl]-piperidine
(L11) from piperidinyl-acetaldehyde diethyl acetal (I11)
Piperdine (3.0 g, 35.2 mmol), bromoacetaldehyde diethyl acetal
(6.94 g, 35.2 mmol), KI (5.85 g, 35.2 mmol), and K2CO3 (4.87 g,
35.2 mmol) were mixed in DMF (60 mL), and the resulting
suspension was stirred at 110 ◦C for 10 h. DMF was removed under
vacuum, and the residue washed three times with Et2O (3¥ 20 mL).
The combined organic phases were dried over anhydrous NaSO4
and concentrated in vacuo. The resulting residue was purified by
chromatography (ethyl acetate/hexane), and yielded I11 (5.9 g,
83%) as colorless oil. 1H NMR (300 MHz, CDCl3): d 4.64 (t, J =
5.1 Hz, 1H, CHCH2), 3.75-3.55 (m, 4H, CH3CH2O), 2.50 (d, J =
5.1 Hz, 2H, CHCH2N), 2.46 (t, J = 5.4 Hz, 4H, NCH2CH2),
1.60-1.40 (m, 6H, -CH2CH2CH2CH2CH2-), 1.20(t, J = 7.2 Hz,
6H, CH3CH2O).
L11 has been prepared similarly to L7, starting from 3,5-
dimethyl-pyrazole (0.77 g, 8.00 mmol), I11 (0.81 g, 4.00 mmol),
and p-toluenesulfonic acid (0.05 g). Yield: 0.90 g (73%). 1H NMR
(300 MHz, CDCl3): d 6.24 (t, J = 6.6 Hz, 1H, CHCH2), 5.76 (s, 2H,
Pz-H), 3.48 (d, J = 6.6 Hz, 2H, CHCH2N), 2.38 (t, J = 5.6 Hz, 4H,
NCH2CH2), 2.27 (s, 6H, Pz-CH3), 2.19 (s, 6H, Pz-CH3), 1.49-1.35
(m, 6H, -CH2CH2CH2CH2CH2-). 13C{1H} NMR (75.47 MHz,
CDCl3): d 147.93, 140.04 (s, C-N(Pz)), 106.55 (s, CH(Pz)), 69.82
(s, N-CH-CH2), 60.80 (s, CH-CH2-NH2), 54.98, 26.37, 24.36 (s,
C(Piperidine)), 13.90, 11.48 (s, CH3(pz)).
Synthesis of ligands, L9, L12, L13
2,2-Bis-(3,5-methyl-pyrazol-1-yl)-ethanamine (L13). N-[2,2-
bis-(3,5-methyl-pyrazol-1-yl)-ethane]-1,8-naphthalimide (3.0 g,
7.3 mmol) was dissolved in ethanol (15 mL). Hydrazine
monohydrate (3.0 mL) was added, and the mixture refluxed for
3 days. After cooling to r.t., the solvent and excess hydrazine
were removed in vacuo. The resulting residue was purified by
chromatography (ethyl acetate/hexane), and yielded L13 0.9 g

































































(53%) as a yellow powder. 1H NMR (300 MHz, CDCl3): d 6.17
(t, J = 6.9 Hz, 1H, Pz2CHCH2), 5.79 (s, 2H, Pz-H), 3.69 (d,
J = 6.9 Hz, 2H, CHCH2NH), 2.21 (s, 6H, Pz-CH3), 2.07 (s, 6H,
Pz-CH3). 13C{1H} NMR (75.47 MHz, CDCl3): d 148.16, 140.26
(s, C-N(Pz)), 107.13 (s, CH(Pz)), 74.82 (s, N-CH-CH2), 44.69 (s,
CH-CH2-NH2), 13.83, 11.08 (s, CH3(Pz)).
N-hexyl-2,2-bis(3,5-dimethyl-pyrazol)-1-yl-ethanamine (L9).
n-hexanal (2.00 g, 20 mmol) was added to a solution of L13
(4.67 g, 20 mmol) in dry methanol (20 mL), and the mixture was
heated to reflux overnight. After cooling to r.t., excess of NaBH4
(1.50 g, 40 mmol) was added in portions and the mixture stirred
for 6 h. The solvent was removed in vacuo, and the residue was
taken up in 30 mL of hexane. The organic layer was washed
with water (3 ¥ 100 mL), dried over anhydrous NaSO4, and
the solvent removed by rotary evaporation to yield L9 (5.65 g,
89%) as white solid. 1H NMR (300 MHz, CDCl3): d 6.38 (t, J =
7.2 Hz, 1H, Pz2CHCH2), 5.82 (s, 2H, Pz-H), 3.73 (d, J = 7.2 Hz,
2H, CHCH2NH), 2.50 (t, J = 7.2 Hz, 2H, NCH2), 2.24(s, 6H,
Pz-CH3), 2.15 (s, 6H, Pz-CH3), 1.34-0.87(m, 11H, (CH2)4CH3).
N-(1-ferrocenyl-methyl)-2,2-bis(3,5-dimethyl-pyrazol)-1-yl-
ethanamine (L12). This compound was prepared similarly to L9
as a white solid from ferrocenecarboxaldehyde (4.28 g, 20 mmol),
L13 (4.67 g, 20 mmol), and NaBH4 (1.50 g, 40 mmol). Yield: 7.51 g
(87%). 1H NMR (300 MHz, CDCl3): d 6.38 (t, J = 7.2 Hz, 1H,
CHCH2), 5.80 (s, 2H, Pz-H), 4.18-4.05 (m, 4H, Cp-H), 4.05 (s,
5H, Cp’-H), 3.70 (d, J = 7.2 Hz, 2H, NH-CH2-Fc), 3.51 (s, 3H,
NCH2Cp), 2.21 (s, 6H, Pz-CH3), 2.17 (s, 6H, Pz-CH3). 13C{1H}
NMR (75.47 MHz, CDCl3): d 148.06, 139.81 (s, C-N(Pz)), 106.74
(s, CH(Pz)), 87.30 (ipso-C C5H4-Cp), 68.31 (C5H5-Cp), 67.69,
67.53 (s, C5H4-Cp), 71.06 (s, N-CH-CH2), 51.25 (s, CH-CH2-NH),
48.25 (s, NH-CH2-Cp), 13.67, 10.93 (s, CH3(pz)).
Synthesis of complexes 2, 4, 5, 7, 9–14
The complexes were all prepared via a similar procedure, in yields
of 88–95%, illustrated below for 2.
[Cr(L2)Cl3] (2). To a solution of (6-methyl-pyridin-2-yl)-
bis(3,5-dimethylpyrazol-1-yl)methane L2 (0.127 g, 0.43 mmol) in
dry THF (10 mL) was added [CrCl3(THF)3] (0.161 g, 0.43 mmol),
giving a light green precipitate. The resulting mixture was stirred
at r.t. for 8 h. The solvent was evaporated to about one-third of
its original volume and 10 mL of Et2O was added to complete
precipitation. The product was collected by filtration, washed
with Et2O (10 mL), and dried in vacuo, yielding 2 (0.180 g, 92%).
Anal. Calcd for C17H21Cl3CrN5 (%): C, 45.00; H, 4.66; N, 15.43.
Found: C, 45.19; H, 4.91; N, 14.74. IR (KBr, cm-1): 1612(nC=N(Py)),
1559(nC=N(Pz)).
[Cr(L4)Cl3] (4). Yield: 89%. Anal. Calcd for
C17H24Cl3CrN6·0.5THF (%):C, 45.03; H, 5.57; N, 16.58. Found:
C, 44.34; H, 5.40; N, 16.54. IR (KBr, cm-1): 1604(nC=N(Imidazole)),
1559(nC=N(Pz)).
[Cr(L5)Cl3] (5). Yield: 95%. Anal. Calcd for C19H22Cl3CrN6
(%): C, 46.31; H, 4.50; N, 17.05. Found: C, 46.89; H, 4.62; N,
16.60. IR (KBr, cm-1): 1617(nC=N(Benzimidazole)), 1562(nC=N(Pz)).
[Cr(L7)Cl3] (7). Yield: 88%. Anal. Calcd for
C17H24Cl3CrN6·H2O (%): C, 41.77; H, 5.36; N, 17.19. Found: C,
41.33; H, 5.37; N, 16.55. IR (KBr, cm-1): 1563(nC=N(Pz)).
[Cr(L9)Cl3] (9). Yield: 92%. Anal. Calcd for
C18H31Cl3CrN5·0.25THF (%):C, 46.21; H, 6.74; N, 14.18.
Found: C, 45.66; H, 6.78; N, 13.15. IR (KBr, cm-1): 1560(nC=N(Pz)).
[Cr(L10)Cl3] (10). Yield: 91%. Anal. Calcd for C18H29Cl3CrN5
(%): C, 45.63; H, 6.17; N, 14.78. Found: C, 45.85; H, 6.29; N,
14.39. IR (KBr, cm-1): 3089(nN-H), 1559(nC=N(Pz)). MS (ESI): m/z =
495 {[M] + Na+}; m/z = 437 [M - Cl]+.
[Cr(L11)Cl3] (11). Yield: 90%. Anal. Calcd for C17H27Cl3CrN5
(%): C, 44.41; H, 5.92; N, 15.23. Found: C, 44.17; H, 5.93; N,
14.50. IR (KBr, cm-1): 3088(nN-H), 1558(nC=N(Pz)).
[Cr(L12)Cl3] (12). Yield: 91%. Anal. Calcd for
C23H29Cl3CrFeN5 (%):C, 46.84; H, 4.96; N, 11.88. Found:
C, 46.29; H, 4.94; N, 11.52. IR (KBr, cm-1): 3089(nN-H),
1626(nC=C(Cp)), 1559(nC=N(Pz)).MS (ESI): m/z = 611 {[M] + Na+}.
[Cr(L13)Cl3] (13). Yield: 93%. Anal. Calcd for C12H19Cl3CrN5
(%): C, 36.28; H, 4.98; N, 17.48. Found: C, 36.28; H, 4.98; N,
17.48. IR (KBr, cm-1): 3091(nN-H), 1560(nC=N(Pz)). MS (ESI): m/z =
413 {[M] + Na+}.
[Cr(L14)Cl3] (14). Yield: 92%. Calcd for
C15H17Cl3CrN5·0.5THF·0.5H2O (%): C, 43.37; H, 4.71; N,
14.88. Found: C, 42.48; H, 4.33; N, 14.69. IR (KBr, cm-1):
3094(nN-H) 1602(nC=C(Ph)), 1559(nC=N(Pz)).
Trimerisation of ethylene. A 200 mL stainless steel reactor
was dried at 120 ◦C for 3 h under vacuum, and then cooled
down to 80 ◦C. Under ethylene atmosphere, the reactor was
charged with toluene (50 mL) and then the mixture of the catalyst
and an appropriate amount of MAO in toluene (10 mL). The
reactor was immediately pressurized. After 30 min, the reaction
was stopped by cooling the system at 0 ◦C, depressurizing, and
quenched by addition of 5 mL of H2O. A small sample of the
upper-layer solution was filtered through a layer of Celite and
analysed by GC. The individual oligomerisation products were
identified by GC-MS. The remainder of the upper-layer solution
was filtered to isolate the solid polymeric products. The solid
products were suspended in 10% aq. HCl and stirred for 24 h,
and the precipitated polyethylene was collected by filtration, dried
under reduced pressure and weighed.
X-ray crystallography
The crystals were mounted on quartz fibers and X-ray data were
collected on a Bruker AXS APEX diffractometer, equipped with a
CCD detector at -50 ◦C, using Mo-Ka radiation (l = 0.71073 Å).
The data were corrected for Lorentz and polarization effects with
the SMART suite of programs and for absorption effects with
SADABS. Structure solution and refinement were carried out with
the SHELXTL suite of programs. The structures were solved by
direct methods to locate the heavy atoms, followed by difference
maps for the light non-hydrogen atoms.
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